BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 36212050)

  • 1. Impulse Oscillometry, Small Airways Disease, and Extra-Fine Formulations in Asthma and Chronic Obstructive Pulmonary Disease: Windows for New Opportunities.
    Chetta A; Facciolongo N; Franco C; Franzini L; Piraino A; Rossi C
    Ther Clin Risk Manag; 2022; 18():965-979. PubMed ID: 36212050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the relevance and extent of small airways dysfunction in asthma (ATLANTIS): baseline data from a prospective cohort study.
    Postma DS; Brightling C; Baldi S; Van den Berge M; Fabbri LM; Gagnatelli A; Papi A; Van der Molen T; Rabe KF; Siddiqui S; Singh D; Nicolini G; Kraft M;
    Lancet Respir Med; 2019 May; 7(5):402-416. PubMed ID: 30876830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small Airways, Big Problem: Extrafine beclomethasone/formoterol in asthma and chronic obstructive pulmonary disease.
    Hasan A; Mukherjee P; Chhowala S; Lopez M; Chhajed PN
    Lung India; 2021; 38(4):350-358. PubMed ID: 34259174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of small-airways disease using alveolar nitric oxide and impulse oscillometry in asthma and COPD.
    Williamson PA; Clearie K; Menzies D; Vaidyanathan S; Lipworth BJ
    Lung; 2011 Apr; 189(2):121-9. PubMed ID: 21174112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small airway inflammation and extrafine inhaled corticosteroids plus long-acting beta
    Pirina P; Foschino Barbaro MP; Paleari D; Spanevello A
    Respir Med; 2018 Oct; 143():74-81. PubMed ID: 30261996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of small airways dysfunction in asthma with- and without-fixed airflow obstruction and chronic obstructive pulmonary disease.
    Pornsuriyasak P; Khiawwan S; Rattanasiri S; Unwanatham N; Petnak T
    Asian Pac J Allergy Immunol; 2021 Dec; 39(4):296-303. PubMed ID: 31175719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extrafine inhaled corticosteroid therapy in the control of asthma.
    Ivancsó I; Böcskei R; Müller V; Tamási L
    J Asthma Allergy; 2013; 6():69-80. PubMed ID: 23776339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of extrafine formulations of inhaled corticosteroids/long-acting beta-2 agonist combinations on patient-related outcomes in asthma and COPD.
    Scichilone N; Benfante A; Morandi L; Bellini F; Papi A
    Patient Relat Outcome Meas; 2014; 5():153-62. PubMed ID: 25473323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Relevance of Targeting Treatment to Small Airways in Asthma and COPD.
    Santus P; Radovanovic D; Pecchiari M; Ferrando M; Tursi F; Patella V; Braido F
    Respir Care; 2020 Sep; 65(9):1392-1412. PubMed ID: 32209703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upper airway symptoms and Small Airways Disease in Chronic Obstructive Pulmonary Disease, COPD.
    Obling N; Rangelov B; Backer V; Hurst JR; Bodtger U
    Respir Med; 2022 Jan; 191():106710. PubMed ID: 34920372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Manifesto on small airway involvement and management in asthma and chronic obstructive pulmonary disease: an Interasma (Global Asthma Association - GAA) and World Allergy Organization (WAO) document endorsed by Allergic Rhinitis and its Impact on Asthma (ARIA) and Global Allergy and Asthma European Network (GA
    Braido F; Scichilone N; Lavorini F; Usmani OS; Dubuske L; Boulet LP; Mosges R; Nunes C; Sanchez-Borges M; Ansotegui IJ; Ebisawa M; Levi-Schaffer F; Rosenwasser LJ; Bousquet J; Zuberbier T; Canonica GW; Cruz A; Yanez A; Yorgancioglu A; Deleanu D; Rodrigo G; Berstein J; Ohta K; Vichyanond P; Pawankar R; Gonzalez-Diaz SN; Nakajima S; Slavyanskaya T; Fink-Wagner A; Loyola CB; Ryan D; Passalacqua G; Celedon J; Ivancevich JC; Dobashi K; Zernotti M; Akdis M; Benjaponpitak S; Bonini S; Burks W; Caraballo L; El-Sayed ZA; Fineman S; Greenberger P; Hossny E; Ortega-Martell JA; Saito H; Tang M; Zhang L; ; ;
    World Allergy Organ J; 2016; 9(1):37. PubMed ID: 27800118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prevalence of small airways disease in adult asthma: A systematic literature review.
    Usmani OS; Singh D; Spinola M; Bizzi A; Barnes PJ
    Respir Med; 2016 Jul; 116():19-27. PubMed ID: 27296816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of the small airways in the pathophysiology of asthma and chronic obstructive pulmonary disease.
    Bonini M; Usmani OS
    Ther Adv Respir Dis; 2015 Dec; 9(6):281-93. PubMed ID: 26037949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Techniques for assessing small airways function: Possible applications in asthma and COPD.
    Konstantinos Katsoulis K; Kostikas K; Kontakiotis T
    Respir Med; 2016 Oct; 119():e2-e9. PubMed ID: 23764129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing and accessing the small airways; implications for asthma management.
    Scichilone N; Contoli M; Paleari D; Pirina P; Rossi A; Sanguinetti CM; Santus P; Sofia M; Sverzellati N
    Pulm Pharmacol Ther; 2013 Apr; 26(2):172-9. PubMed ID: 23073337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Manifesto on small airway involvement and management in asthma and chronic obstructive pulmonary disease: an Interasma (Global Asthma Association - GAA) and World Allergy Organization (WAO) document endorsed by Allergic Rhinitis and its Impact on Asthma (ARIA) and Global Allergy and Asthma European Network (GA
    Braido F; Scichilone N; Lavorini F; Usmani OS; Dubuske L; Boulet LP; Mosges R; Nunes C; Sánchez-Borges M; Ansotegui IJ; Ebisawa M; Levi-Schaffer F; Rosenwasser LJ; Bousquet J; Zuberbier T; Canonica GW; ; ; ;
    Asthma Res Pract; 2016; 2():12. PubMed ID: 27965780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Are Small Airways the Key to Understanding Pathophysiology and Treatment Efficacy in Chronic Obstructive Pulmonary Diseases?].
    Koehler U; Hildebrandt O; Koehler N; Sohrabi K
    Pneumologie; 2018 Nov; 72(11):790-796. PubMed ID: 30408831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "Current place of impulse oscillometry in the assessment of pulmonary diseases.".
    Bednarek M; Grabicki M; Piorunek T; Batura-Gabryel H
    Respir Med; 2020; 170():105952. PubMed ID: 32843158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advantage of impulse oscillometry over spirometry to diagnose chronic obstructive pulmonary disease and monitor pulmonary responses to bronchodilators: An observational study.
    Saadeh C; Saadeh C; Cross B; Gaylor M; Griffith M
    SAGE Open Med; 2015; 3():2050312115578957. PubMed ID: 26770777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lung penetration and patient adherence considerations in the management of asthma: role of extra-fine formulations.
    Scichilone N; Spatafora M; Battaglia S; Arrigo R; Benfante A; Bellia V
    J Asthma Allergy; 2013; 6():11-21. PubMed ID: 23378776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.